Full Text View
Tabular View
Study Results
Related Studies
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
This study has been completed.
Study NCT00957372   Information provided by Bial - Portela C S.A.

First Received on August 10, 2009.   Last Updated on August 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial